Expression of HOXA genes in patients with multiple myeloma
Heidi Rye Hudlebusch1, Marianne Lodahl, Hans E Johnsen
1Department of Hematology L, Herlev Hospital, University of Copenhagen, 2730 Herlev, Denmark.
Abstract:
Multiple Myeloma (MM) is an incurable B-cell malignancy characterized by uncontrolled growth of plasma cells (PCs) in the bone marrow. The pathogenesis of MM is complex and still not fully understood. The HOX genes encode a family of homeodomain containing transcription factors which are crucial for embryonic development and differentiation. The HOX genes are also involved in hematopoiesis and have been shown to be dysregulated in leukemia suggesting a role in leukemogenesis. We hypothesized that expression of the HOX genes might also be of importance in MM. We screened FACS-sorted malignant PCs from a panel of 32 MM patients for the expression of HOXA 2, 3, 4, 7, 9, 10, and 11 genes by RT-PCR assays specific for each gene. We found that 9.4% (3/32) of the MM patients expressed the tested HOX genes in their PCs suggesting that HOXA genes are frequently dysregulated and might have an oncogenic potential in MM.
Insights
HOXA genes may play a role in multiple myeloma (MM), an incurable cancer. This study found HOXA gene expression in malignant plasma cells of MM patients, suggesting potential oncogenic activity.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Genetics
Background:
- Multiple Myeloma (MM) is a fatal B-cell malignancy driven by uncontrolled plasma cell proliferation.
- The complex pathogenesis of MM remains incompletely understood.
- HOX genes are critical for development and implicated in hematopoiesis and leukemogenesis.
Purpose of the Study:
- To investigate the potential role of HOXA gene expression in the pathogenesis of Multiple Myeloma.
- To screen for the expression of specific HOXA genes (HOXA 2, 3, 4, 7, 9, 10, 11) in malignant plasma cells of MM patients.
Main Methods:
- Malignant plasma cells were isolated from 32 MM patients using Fluorescence-Activated Cell Sorting (FACS).
- Expression of HOXA 2, 3, 4, 7, 9, 10, and 11 genes was quantified using gene-specific Reverse Transcription Polymerase Chain Reaction (RT-PCR) assays.
Main Results:
- HOXA gene expression was detected in the malignant plasma cells of 9.4% (3 out of 32) of the studied MM patients.
- This finding indicates dysregulation of HOXA genes in a subset of MM cases.
Conclusions:
- HOXA gene dysregulation may contribute to the oncogenesis of Multiple Myeloma.
- Further research is warranted to elucidate the specific mechanisms and functional significance of HOXA genes in MM.
More Related Videos
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...


